# Sotera Health Co: filings

SHC · Nasdaq · CIK 1822479 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shc.md) · [Financials](/companies/shc/financials.md) · [Filings](/companies/shc/filings.md) · [Insiders](/companies/shc/insiders.md)

## Reports and events: 113 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 141, 8-K 76, 3 28, 10-Q 17, SCHEDULE 13G/A 16, 424B7 12, CORRESP 9, 144 8, DEFA14A 8, 10-K 6, DEF 14A 6, SC 13G/A 6, ARS 4, S-1/A 4, SCHEDULE 13G 4, SD 4, UPLOAD 4, SC 13G 3, 3/A 2, 424B4 2, 8-K/A 2, DRS 2, DRS/A 2, EFFECT 2, S-1 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, DEFR14A 1, DRSLTR 1, FWP 1, PRE 14A 1, S-3ASR 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 07:17 ET | [8-K](/filings/0001822479-26-000050.md) | 5.02 Departure or appointment of officers or directors | 0001822479-26-000050 |
| 2026-08-06 | 16:04 ET | [10-Q](/filings/0001822479-26-000047.md) | Quarterly report, period 2026-06-30 | 0001822479-26-000047 |
| 2026-08-06 | 07:19 ET | [8-K](/filings/0001822479-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-26-000044 |
| 2026-05-22 | 16:09 ET | [8-K](/filings/0001822479-26-000034.md) | 5.07 Shareholder vote results | 0001822479-26-000034 |
| 2026-05-20 | 16:10 ET | [8-K](/filings/0001193125-26-232585.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-232585 |
| 2026-05-13 | 16:11 ET | [8-K](/filings/0001193125-26-221630.md) | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-221630 |
| 2026-05-05 | 16:19 ET | [10-Q](/filings/0001822479-26-000031.md) | Quarterly report, period 2026-03-31 | 0001822479-26-000031 |
| 2026-05-05 | 07:13 ET | [8-K](/filings/0001822479-26-000028.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822479-26-000028 |
| 2026-04-08 | 16:30 ET | [DEF 14A](/filings/0001104659-26-040937.md) | Proxy statement, period 2026-05-21 | 0001104659-26-040937 |
| 2026-03-16 | 07:14 ET | [8-K](/filings/0001822479-26-000019.md) | 5.02 Departure or appointment of officers or directors | 0001822479-26-000019 |
| 2026-03-06 | 17:29 ET | [8-K](/filings/0001193125-26-096983.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096983 |
| 2026-02-24 | 16:15 ET | [10-K](/filings/0001822479-26-000015.md) | Annual report, period 2025-12-31 | 0001822479-26-000015 |
| 2026-02-24 | 07:14 ET | [8-K](/filings/0001822479-26-000012.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822479-26-000012 |
| 2026-02-05 | 07:35 ET | [8-K](/filings/0001822479-26-000007.md) | 5.02 Departure or appointment of officers or directors | 0001822479-26-000007 |
| 2026-01-12 | 07:24 ET | [8-K](/filings/0001822479-26-000004.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822479-26-000004 |
| 2025-11-10 | 16:06 ET | [8-K](/filings/0001193125-25-274199.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-274199 |
| 2025-11-04 | 16:02 ET | [10-Q](/filings/0001822479-25-000054.md) | Quarterly report, period 2025-09-30 | 0001822479-25-000054 |
| 2025-11-04 | 07:07 ET | [8-K](/filings/0001822479-25-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000050 |
| 2025-09-18 | 17:01 ET | [8-K](/filings/0001193125-25-207549.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-207549 |
| 2025-09-05 | 16:16 ET | [8-K](/filings/0001193125-25-197231.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-197231 |
| 2025-08-08 | 16:19 ET | [10-Q](/filings/0001822479-25-000044.md) | Quarterly report, period 2025-06-30 | 0001822479-25-000044 |
| 2025-08-08 | 07:44 ET | [8-K](/filings/0001822479-25-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000041 |
| 2025-07-24 | 07:31 ET | [8-K](/filings/0001822479-25-000036.md) | 7.01 Regulation FD disclosure | 0001822479-25-000036 |
| 2025-05-23 | 16:07 ET | [8-K](/filings/0001822479-25-000028.md) | 5.07 Shareholder vote results | 0001822479-25-000028 |
| 2025-05-01 | 16:05 ET | [10-Q](/filings/0001822479-25-000025.md) | Quarterly report, period 2025-03-31 | 0001822479-25-000025 |
| 2025-05-01 | 07:45 ET | [8-K](/filings/0001822479-25-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000022 |
| 2025-04-10 | 07:32 ET | [DEF 14A](/filings/0001104659-25-033563.md) | Proxy statement, period 2025-05-21 | 0001104659-25-033563 |
| 2025-04-04 | 07:31 ET | [8-K](/filings/0001822479-25-000018.md) | 7.01 Regulation FD disclosure | 0001822479-25-000018 |
| 2025-02-27 | 16:02 ET | [10-K](/filings/0001822479-25-000015.md) | Annual report, period 2024-12-31 | 0001822479-25-000015 |
| 2025-02-27 | 07:16 ET | [8-K](/filings/0001822479-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000012 |
| 2025-01-14 | 07:35 ET | [8-K](/filings/0001822479-25-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822479-25-000006 |
| 2025-01-06 | 16:38 ET | [8-K](/filings/0001822479-25-000003.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001822479-25-000003 |
| 2024-11-20 | 09:16 ET | [8-K](/filings/0001193125-24-262222.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-262222 |
| 2024-11-05 | 16:24 ET | [10-Q](/filings/0001822479-24-000049.md) | Quarterly report, period 2024-09-30 | 0001822479-24-000049 |
| 2024-11-05 | 07:08 ET | [8-K](/filings/0001822479-24-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000046 |
| 2024-09-06 | 16:36 ET | [8-K](/filings/0001193125-24-215204.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-215204 |
| 2024-08-05 | 16:08 ET | [10-Q](/filings/0001822479-24-000041.md) | Quarterly report, period 2024-06-30 | 0001822479-24-000041 |
| 2024-08-05 | 07:15 ET | [8-K](/filings/0001822479-24-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000038 |
| 2024-08-01 | 07:04 ET | [8-K](/filings/0001822479-24-000036.md) | 5.02 Departure or appointment of officers or directors | 0001822479-24-000036 |
| 2024-05-30 | 17:17 ET | [8-K](/filings/0001822479-24-000029.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001822479-24-000029 |
| 2024-05-24 | 16:25 ET | [8-K](/filings/0001822479-24-000027.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001822479-24-000027 |
| 2024-05-23 | 17:16 ET | [8-K](/filings/0001822479-24-000024.md) | 7.01 Regulation FD disclosure | 0001822479-24-000024 |
| 2024-05-16 | 16:11 ET | [8-K](/filings/0001822479-24-000022.md) | 7.01 Regulation FD disclosure | 0001822479-24-000022 |
| 2024-05-02 | 16:40 ET | [10-Q](/filings/0001822479-24-000020.md) | Quarterly report, period 2024-03-31 | 0001822479-24-000020 |
| 2024-05-02 | 11:57 ET | [8-K/A](/filings/0001822479-24-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000017 |
| 2024-05-02 | 07:14 ET | [8-K](/filings/0001822479-24-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000015 |
| 2024-04-11 | 16:05 ET | [DEF 14A](/filings/0001193125-24-093193.md) | Proxy statement, period 2024-05-23 | 0001193125-24-093193 |
| 2024-03-04 | 17:24 ET | [8-K](/filings/0001193125-24-058025.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-058025 |
| 2024-02-27 | 16:34 ET | [10-K](/filings/0001822479-24-000011.md) | Annual report, period 2023-12-31 | 0001822479-24-000011 |
| 2024-02-27 | 07:13 ET | [8-K](/filings/0001822479-24-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000008 |

Page 1 of 3. [Older](/companies/shc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:37 ET. No prices; not investment advice.